Name | HJM-561 |
---|
Description | HJM-561 is a potent, selective, orally bioavailable EGFR PROTAC. HJM-561 overcomes osimertinib (HY-15772)-resistant EGFR triple mutations and has anti-tumor activity[1]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C45H51ClN9O5P |
---|---|
Molecular Weight | 864.37 |